Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP551493.RA5G5NcaAgg1-FCO7F8EzPaZFy4YK5kdsISq0g6esHviA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP551493.RA5G5NcaAgg1-FCO7F8EzPaZFy4YK5kdsISq0g6esHviA130_assertion type Assertion NP551493.RA5G5NcaAgg1-FCO7F8EzPaZFy4YK5kdsISq0g6esHviA130_head.
- NP551493.RA5G5NcaAgg1-FCO7F8EzPaZFy4YK5kdsISq0g6esHviA130_assertion description "[Univariate analysis of collected data demonstrated that the expressions of O(6)-MGMT and MRP-1 detected by immunohistochemistry, in addition to the consistent factors, including preoperative Karnofsky performance scale (KPS), radical surgery, and tumor location and extension, were significant prognostic factors for the overall survival (OS) of patients with glioblastoma, who received nimustine (ACNU)-based chemotherapy in association with surgery and radiotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551493.RA5G5NcaAgg1-FCO7F8EzPaZFy4YK5kdsISq0g6esHviA130_provenance.
- NP551493.RA5G5NcaAgg1-FCO7F8EzPaZFy4YK5kdsISq0g6esHviA130_assertion evidence source_evidence_literature NP551493.RA5G5NcaAgg1-FCO7F8EzPaZFy4YK5kdsISq0g6esHviA130_provenance.
- NP551493.RA5G5NcaAgg1-FCO7F8EzPaZFy4YK5kdsISq0g6esHviA130_assertion SIO_000772 19019175 NP551493.RA5G5NcaAgg1-FCO7F8EzPaZFy4YK5kdsISq0g6esHviA130_provenance.
- NP551493.RA5G5NcaAgg1-FCO7F8EzPaZFy4YK5kdsISq0g6esHviA130_assertion wasDerivedFrom befree-20150227 NP551493.RA5G5NcaAgg1-FCO7F8EzPaZFy4YK5kdsISq0g6esHviA130_provenance.
- NP551493.RA5G5NcaAgg1-FCO7F8EzPaZFy4YK5kdsISq0g6esHviA130_assertion wasGeneratedBy ECO_0000203 NP551493.RA5G5NcaAgg1-FCO7F8EzPaZFy4YK5kdsISq0g6esHviA130_provenance.